Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of a Swiss university hospital: Cross-sectional study

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Russmann, Stefan ^a,b,c   Dowlatshahi, Emmilia A ^a   Printzen, Gert ^b   Habicht, Susanne ^b   Reichen, Jürg ^a,b   Zimmermann, Heinz ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; TRANSFERRIN;

ABDOMINAL PAIN; ADULT; AGE; ALCOHOL CONSUMPTION; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; EMERGENCY WARD; ETHNICITY; FATIGUE; FEMALE; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PATIENT REFERRAL; PREVALENCE; PUBLIC HEALTH; QUESTIONNAIRE; SAMPLE SIZE; SCREENING; SWITZERLAND; UNIVERSITY HOSPITAL; VACCINATION;

ADULT; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALS, UNIVERSITY; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; SWITZERLAND; TRANSFERRIN;

EID: 33847219684     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-5     Document Type: Article

References (24)

1. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version) J Hepatol 2003 38 4 533-540
2. Alter MJ Epidemiology of hepatitis B in Europe and worldwide J Hepatol 2003 39 Suppl 1 S64-9
3. Shepard CW Finelli L Alter MJ Global epidemiology of hepatitis C virus infection Lancet Infect Dis 2005 5 9 558-567
4. Merryweather-Clarke AT Pointon JJ Shearman JD Robson KJ Global prevalence of putative haemochromatosis mutations J Med Genet 1997 34 4 275-278
5. Kelen GD Green GB Purcell RH Chan DW Qaqish BF Sivertson KT Quinn TC Hepatitis B and hepatitis C in emergency department patients N Engl J Med 1992 326 21 1399-1404
6. Mantel N Haenszel WH Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 1959 22 719-748
7. Barros AJ Hirakata VN Alternatives for logistic regression in cross-sectional studies: An empirical comparison of models that directly estimate the prevalence ratio BMC Med Res Methodol 2003 3 21
8. Chapko MK Sloan KL Davison JW Dufour DR Bankson DD Rigsby M Dominitz JA Cost effectiveness of testing strategies for chronic hepatitis C Am J Gastroenterol 2005 100 3 607-615
9. Seeff LB Miller RN Rabkin CS Buskell-Bales Z Straley-Eason KD Smoak BL Johnson LD Lee SR Kaplan EL 45-year follow-up of hepatitis C virus infection in healthy young adults Ann Intern Med 2000 132 2 105-111
10. Bellentani S Tiribelli C Saccoccio G Sodde M Fratti N De Martin C Cristianini G Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study Hepatology 1994 20 6 1442-1449
11. Kammerlander R Zimmermann H [Epidemiology of hepatitis B in Switzerland] Soz Praventivmed 1998 43 Suppl 1 S27-30, S101-4
12. Bart PA Jacquier P Zuber PL Lavanchy D Frei PC Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery Liver 1996 16 2 110-116
13. Grob PJ Negro F Renner EL [Hepatitis C virus infection. Overview. SEVHEP (Swiss Experts on Viral Hepatitis)] Schweiz Rundsch Med Prax 2000 89 40 1587-1604
14. Broers B Junet C Bourquin M Deglon JJ Perrin L Hirschel B Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995 Aids 1998 12 15 2059-2066
15. Rohrig S Grob PJ [Infection with hepatitis viruses HAV, HBV and HCV as well as with AIDS virus HIV in drug addicts of the Zurich street scene - a prevalence study] Schweiz Med Wochenschr 1990 120 17 621-629
16. Somaini B Wang J Perozo M Kuhn F Meili D Grob P Flepp M A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, Switzerland AIDS Care 2000 12 4 449-460
17. Steffen T Blattler R Gutzwiller F Zwahlen M HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme Eur J Public Health 2001 11 4 425-430
18. Poynard T Bedossa P Opolon P Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 1997 349 9055 825-832
19. A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium Gut 1997 41 6 841-844
20. Himmelmann A Bortoluzzi L Jansen S Fehr J [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland] Schweiz Med Wochenschr 2000 130 31-32 1112-1119
21. Adams PC Reboussin DM Barton JC McLaren CE Eckfeldt JH McLaren GD Dawkins FW Acton RT Harris EL Gordeuk VR Leiendecker-Foster C Speechley M Snively BM Holup JL Thomson E Sholinsky P Hemochromatosis and iron-overload screening in a racially diverse population N Engl J Med 2005 352 17 1769-1778
22. Schmitt B Golub RM Green R Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: Systematic review for the American College of Physicians Ann Intern Med 2005 143 7 522-536
23. Waalen J Felitti V Gelbart T Ho NJ Beutler E Penetrance of hemochromatosis Blood Cells Mol Dis 2002 29 3 418-432
24. Beutler E Felitti VJ Koziol JA Ho NJ Gelbart T Penetrance of 845G→ A (C282Y) HFE hereditary haemochromatosis mutation in the USA Lancet 2002 359 9302 211-218